Headline Details

How the Actavis deal upended Allergan No. 2's CEO ambitions

Published on: Tue, 03 Feb 2015 18:26:51 UTC
News Agency: Reuters
NEW YORK, Feb 3 (Reuters) - For two decades, Allergan Inc president Doug Ingram labored to transform the Botox-maker from a sleepy eye care upstart to a global aesthetics giant. He was just a few months away from getting the top job when a merger deal with Actavis Plc in November thwarted his ambitions.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
Saudi camel beauty pageant cracks down on cosmetic enhancements BBC
Sauti Sol singer Chimano hailed in Kenya for coming out as gay BBC
Human remains found in car linked to 45-year-old cold case BBC
China warns nations will 'pay price' for Olympic boycott BBC
Farm laws: India farmers end protest after government accepts demands BBC